An Evaluation of the Effect of Spironolactone on the Risk of New-Onset Diabetes in a Cohort of Patients with Heart Failure

被引：0
|
作者：
De Denus, Simon [1 ]
Korol, Sandra [1 ]
O'Meara, Eileen [1 ]
Rouleau, Jean L. [1 ]
White-Guay, Brian [2 ]
Dorais, Marc [3 ]
Ahmed, Ali [4 ,5 ]
White, Michel [1 ]
Perreault, Sylvie [2 ,3 ]
机构：
[1] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
[2] Univ Montreal, Montreal, PQ, Canada
[3] Sanofi Aventis, Laval, PQ, Canada
[4] Vet Affairs Med Ctr, 50 Irving St NW, Washington, DC 20422 USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF CARDIAC FAILURE | 2016年 / 22卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2016.06.117
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
099
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?
    Sandra Korol
    Michel White
    Eileen O’Meara
    Jean-Lucien Rouleau
    Brian White-Guay
    Marc Dorais
    Ali Ahmed
    Simon de Denus
    Sylvie Perreault
    [J]. European Journal of Clinical Pharmacology, 2019, 75 : 837 - 847
  • [2] Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?
    Korol, Sandra
    White, Michel
    O'Meara, Eileen
    Rouleau, Jean-Lucien
    White-Guay, Brian
    Dorais, Marc
    Ahmed, Ali
    de Denus, Simon
    Perreault, Sylvie
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (06) : 837 - 847
  • [3] An Evaluation of the Effect of Spironolactone on the Risk of New Onset of Diabetes in a Population-Based Study of Patients with Heart Failure
    De Denus, Simon
    Korol, Sandra
    White, Michel
    O'Meara, Eileen
    Jean-Lucien, Rouleau
    Marc, Dorais
    Perreault, Sylvie
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 572 - 572
  • [4] EFFECT OF SPIRONOLACTONE ON THE RISK OF NEW ONSET OF DIABETES AMONG PATIENTS WITH HEART FAILURE: A POPULATION-BASED STUDY
    Perreault, S.
    Korol, S.
    White, M.
    O'Meara, E.
    Rouleau, J.
    Dorais, M.
    de Denus, S.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A636 - A637
  • [5] Higher incidence of new-onset diabetes in patients with heart failure
    Grundy, SM
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 114 (04): : 331 - 332
  • [6] Effectiveness and safety of early treatment with spironolactone for new-onset acute heart failure
    Huang, Cheng-Wei
    Park, Joon S.
    Liu, In-Lu Amy
    Lee, Janet S.
    Kohan, Siamak
    Mefford, Mathew
    Wu, Stefanie S.
    Subject, Christopher C.
    Nguyen, Huong Q.
    Lee, Ming-Sum
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2024, 19 (04) : 267 - 277
  • [7] Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study
    Eurich, D. T.
    Weir, D. L.
    Simpson, S. H.
    Senthilselvan, A.
    McAlister, F. A.
    [J]. DIABETIC MEDICINE, 2016, 33 (05) : 621 - 630
  • [8] Renoprotective effect of tolvaptan in patients with new-onset acute heart failure
    Kin, Hiromi
    Matsumura, Koichiro
    Yamamoto, Yoshihiro
    Fujii, Kenichi
    Otagaki, Munemitsu
    Takahashi, Hiroki
    Park, Haengnam
    Yoshioka, Kei
    Yokoi, Mitsuru
    Sugiura, Tetsuro
    Shiojima, Ichiro
    [J]. ESC HEART FAILURE, 2020, 7 (04): : 1764 - 1770
  • [9] Imaging in the Evaluation of the Patient with New-Onset Heart Failure
    Wong T.C.
    Soman P.
    [J]. Current Cardiovascular Imaging Reports, 2012, 5 (3) : 167 - 172
  • [10] Psoriasis is associated with increased risk of new-onset heart failure: a nationwide cohort study
    Khalid, U.
    Ahlehoff, O.
    Gislason, G.
    Kristensen, S. L.
    Skov, L.
    Torp-Pedersen, C.
    Hansen, P. R.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 500 - 500
12345